載入...
Immunotherapy for the treatment of Alzheimer’s disease: amyloid-β or tau, which is the right target?
Alzheimer’s disease (AD) is characterized by the presence of amyloid plaques composed mainly of amyloid-β (Aβ) protein. Overproduction or slow clearance of Aβ initiates a cascade of pathologic events that may lead to formation of neurofibrillary tangles, neuronal cell death, and dementia. Although i...
Na minha lista:
| 發表在: | Immunotargets Ther |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2013
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4918231/ https://ncbi.nlm.nih.gov/pubmed/27471697 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/ITT.S40131 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|